COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response-Reference-Cited by-同舟云学术

COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response

Published:2021-01-09 Issue:10 Volume:28 Page:3384-3395
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Zabalza Ana¹^ORCID,Cárdenas‐Robledo Simón¹^ORCID,Tagliani Paula¹,Arrambide Georgina¹,Otero‐Romero Susana¹^ORCID,Carbonell‐Mirabent Pere¹,Rodriguez‐Barranco Marta¹,Rodríguez‐Acevedo Breogán¹,Restrepo Vera Juan Luis¹,Resina‐Salles Mireia¹,Midaglia Luciana¹,Vidal‐Jordana Angela¹^ORCID,Río Jordi¹,Galan Ingrid¹,Castillo Joaquin¹,Cobo‐Calvo Álvaro¹,Comabella Manuel¹^ORCID,Nos Carlos¹,Sastre‐Garriga Jaume¹^ORCID,Tintore Mar¹,Montalban Xavier¹

Affiliation:

1. Servei de Neurologia‐Neuroimmunologia Centre d'Esclerosi Múltiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca Hospital Universitari Vall d'Hebron Departament de Medicina Universitat Autònoma de Barcelona Barcelona Spain

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14690

Reference37 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. Keeping standards of multiple sclerosis care through the COVID‐19 pandemic;Sastre‐Garriga J;Mult Scler J,2020

3. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS).Dades actualitzades SARS‐CoV‐2.https://aquas.gencat.cat/ca/actualitat/ultimes‐dades‐coronavirus/. Published 2020. Accessed October 14 2020.

4. Infections in patients diagnosed with multiple sclerosis: A multi-database study

5. Infections in patients with multiple sclerosis: Implications for disease-modifying therapy

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022;Multiple Sclerosis Journal;2024-01-21

2. The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders;Multiple Sclerosis and Related Disorders;2024-01

3. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study;Journal of Clinical Medicine;2023-11-23

4. Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era;Infectious Diseases;2023-11-02

5. Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management;Multiple Sclerosis and Related Disorders;2023-11